🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open-label study of Serplulimab plus chemotherapy (Ca...
Status
Active Not Recruiting
Location
Alabama Oncology
Start Date
2022-11-18
Trial ID
NCT05468489
This is a Phase II, single arm, multicenter study designed to evaluate the ...
Status
Active Not Recruiting
Location
Chongqing University cancer hospital
Start Date
2023-03-07
Trial ID
NCT05765825
Treatments Being Tested
This investigator-initiated, open-label, prospective Phase II clinical tria...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-05-22
Trial ID
NCT06911606
Treatments Being Tested
This study is a randomized, double-blind, multicenter, phase III clinical s...
Status
Active Not Recruiting
Location
OPN-Glendale
Start Date
2022-05-17
Trial ID
NCT05353257
This investigator-initiated, open-label, prospective Phase II clinical tria...
Status
Active Not Recruiting
Location
Guangdong Provincial Perople's Hospital
Start Date
2023-07-07
Trial ID
NCT05957510
Treatments Being Tested
This is an open-label umbrella study conducted in first treatment ES-SCLC p...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 300060
Start Date
2025-11
Trial ID
NCT07172412
Lung cancer remains a leading cause of cancer-related deaths worldwide, wit...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-01
Trial ID
NCT06554535
Treatments Being Tested
This study is a prospective, single-center, single-arm phase II clinical tr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07155122
Treatments Being Tested
Small cell lung cancer(SCLC) has a poor prognosis and a relatively short ov...
Status
Recruiting
Location
Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital
Start Date
2024-04-04
Trial ID
NCT06295926
Treatments Being Tested
To evaluates the effectiveness and safety of Surufatinib combined with Serp...
Status
Unknown
Location
Fujian Cancer Hospital
Start Date
2023-06-01
Trial ID
NCT05882630
Treatments Being Tested